TARS2, SLC9A, SLC7A9, NOS3, NDUFB10, FPGS, and CAD all showed significant changes (P< 0.05) (Figure 4F), showing that glutamine metabolism may play a role in the development and recurrence of PCa. The gene discussed is TARS2; the disease is posterior cortical atrophy.